How to understand the overlap of long COVID, chronic fatigue syndrome/myalgic encephalomyelitis, fibromyalgia and irritable bowel syndromes. — CFSMEATLAS
How to understand the overlap of long COVID, chronic fatigue syndrome/myalgic encephalomyelitis, fibromyalgia and irritable bowel syndromes.
Goldenberg, Don L · Seminars in arthritis and rheumatism · 2024 · DOI
Quick Summary
This study examines how long COVID, ME/CFS, fibromyalgia, and irritable bowel syndrome are similar conditions that all affect the nervous system and immune system together. Rather than being separate diseases, these conditions share common features and may work through the same underlying biological mechanisms. The researchers reviewed existing evidence and found striking similarities in how these conditions develop and affect patients.
Why It Matters
This work is significant because it provides a unifying framework for understanding ME/CFS within a broader spectrum of related neuroimmune conditions, potentially accelerating research and validating patient experiences of symptom overlap. Recognition of these similarities may improve clinical recognition, reduce diagnostic delays, and guide researchers toward common therapeutic targets. For ME/CFS patients, this positioning strengthens the biological legitimacy of the condition and supports advocacy for appropriate research funding and clinical attention.
Observed Findings
Long COVID demonstrates striking phenotypic similarity to CFS/ME, fibromyalgia, and IBS when organ-damage cases are excluded.
Central nervous system dysfunction characterizes all four conditions.
Bidirectional mind-body and neuroimmune mechanisms are shared across long COVID, CFS/ME, FM, and IBS.
Research in long COVID has revealed findings comparable to those previously documented in CFS/ME and fibromyalgia.
Inferred Conclusions
Long COVID, CFS/ME, fibromyalgia, and IBS should be understood as neuroimmune conditions rather than primarily psychiatric or purely organ-specific diseases.
These conditions likely share common underlying pathophysiologic mechanisms involving nervous system and immune system interactions.
A unified conceptual framework may benefit clinical understanding and research approaches for all four conditions.
Remaining Questions
What are the specific molecular and cellular mechanisms underlying the shared neuroimmune dysfunction across these conditions?
Are there patient subgroups within long COVID, CFS/ME, FM, and IBS, or do they represent a spectrum of a single disorder?
Which therapeutic interventions targeting neuroimmune dysfunction would be most effective, and can they be tested across these overlapping conditions?
What This Study Does Not Prove
This systematic review does not establish causality or definitively prove that these conditions are manifestations of a single disease entity. It cannot determine whether observed similarities reflect shared mechanisms or are coincidental features, nor does it identify specific biomarkers or diagnostic tests to distinguish between conditions. The review does not establish treatment efficacy for any of these overlapping conditions.